Business ❯ Healthcare

Healthcare Companies

UnitedHealthcare Molina Healthcare UnitedHealth Group Acadia Healthcare Oncology Services Apollo Hospitals CVS Health Financial Practices Financial Performance Cancer Treatment Oncoclínicas Securities Fraud Financial Reporting United Healthcare Max Healthcare Nutex Health Inc. Private Healthcare Hospital Management Healthcare Services Oncology Ardent Health Pharmaceuticals Diagnostics Manipal Health Enterprises Fortis Healthcare Spinoffs Cardinal Health For-Profit Healthcare Medical Equipment Columbia/HCA Pharmaceutical Companies Dental Market Legal Issues UnitedHealth HCA Healthcare Executives Corporate Governance Fresenius Helios Elevance Health Agilon Health, Inc. Data Security in Healthcare DaVita Stock Performance Hospitals Logistics Corporate Transactions Manipal Group Apollo Hospitals Enterprise Apollo Hospitals Enterprise Ltd Medical Technology Consumer Health Products NMC Group Bankruptcy Filings Regulatory Issues Oncology Clinics Boston Scientific Medical Solutions Healthcare Finance Perrigo Company plc Medical Services Acadia Healthcare Company Pathology Services Nutex Health Healthcare Products and Services Corporate Accountability Medical Devices CVS Health Corporation Financial Disclosures Hapvida Fertility Services Ramsay Health Care Limited Investor Relations Entrepreneurs Publicly Traded Companies Hinge Health Ardent Health, Inc. Abbott Laboratories Financial Issues Healthcare Financing Investment in Healthcare Healthcare Investments Optum Health Medical Networking Pharmaceutical Distribution Pharmacies Healthcare Revenue Global Health Health Insurance Sigma Healthcare Hospital Chains Paras Healthcare

Doximity Shares Plunge After EPS Miss and Weaker Revenue Guide

The forecast points to slower growth tied to weak pharma ad budgets plus higher AI costs.

Cardinal Health Lifts 2026 Profit Outlook After Q3 Beat Despite Sales Miss

UnitedHealth Gets Upgrade as Analysts Bet on Optum Margin Rebound

Ardent Health Investors Urged to Seek Lead Role Before March 9 in Securities Class Action

Ardent Health Investors Get March 9 Deadline Reminder in Securities Class Action

Ardent Health Investors Face March 9 Deadline in Securities Class Action

Ardent Health Securities Suit Draws New Filings as Lead‑Plaintiff Deadline Nears

Ardent Health Class Action Advances as March 9 Lead‑Plaintiff Deadline Nears

Agilon Health Investors Urged to Seek Lead Role in Securities Suit Before March 2 Deadline

Mizuho Reaffirms Buy on UnitedHealth, Touts Medicare Advantage Rate Tailwind

Ardent Health Investors Press Securities Case as Firms Seek Lead Plaintiff by March 9

Law Firms Seek Agilon Health Investors Ahead of March 2 Lead Plaintiff Deadline in Securities Case

Investor Firms Press Ardent Health Class Action Ahead of March 9 Lead-Plaintiff Deadline

Ardent Health Sued in Federal Securities Case Over Receivables and Malpractice Reserves Disclosures

Integer Securities Class Action Moves Forward as Investors Face Feb. 9 Lead-Plaintiff Deadline

Integer Holdings Investors Face Feb. 9 Deadline in EP-Demand Securities Suit

Ardent Health Hit With Securities Class Action Over Receivables and Reserve Disclosures

Competing Securities Class Actions Target Agilon Health Over 2025 Guidance

Judge Says Mangione Evidence Hearing Nears Finish as Prosecutors Drop Some Statements

CVS Lifts 2025 Outlook, Sets 2026 Targets and Unveils AI Consumer Platform